Several international symposia on chronic inflammatory bowel disease over the last few years have contributed to our understanding of the pathophysiology and treatment of this condition. Molecular biology and new analytical techniques have continuously improved our knowledge of mucosal immunology and of inflammatory reactions. Progress in this field is very rapid and has implications for diagnosis and treatment, and makes it important to have a scientific exchange between basic research and clinical practice. This volume, the proceedings of Falk Symposium No. 96, held in Freiburg, Germany, October 30- November 1, 1996, documents the transfer of knowledge between clinicians and basic scientists, and clarifies the definitions used in daily practice such as active disease, refractory diseases or remission. The book will open new aspects for future research and clinical work in the field of inflammatory bowel diseases.
Table of Contents
Part 1: Recent Progress at the Laboratory Bench. Section I. Genetics and Animal Models. Section II. Epidemiology and Environmental Factors. Section III. Inflammatory Cells. Section IV. Inflammation: Effects and Consequences. Section V. Cytokines and Adhesion Molecules. Section VI. State of the Art Lecture. Part 2: Recent Progress at the Bedside. Section VII. Role for Conventional Diagnostic Techniques. Section VIII. New Developments in Diagnosis and Assessment. Section IX. Standards in Medical Treatment. Section X. Experimental Treatment. Section XI. Surgery: Controversies and Recurrence. Section XII. Treatment of Patients with Problems. Section XIII. State of the Art Lecture. Index.